TABULA RASA HEALTHCARE,INC (NASDAQ:TRHC) Files An 8-K Financial Statements and Exhibits

ME Staff 8-k
-
0

TABULA RASA HEALTHCARE,INC (NASDAQ:TRHC) Files An 8-K Financial Statements and Exhibits
Item 9.01 of the Prior 8-K in its entirety. Except for the foregoing, this amendment does not modify or update any other disclosure contained in the Prior 8-K.

Item 9.01 Financial Statements and Exhibits

(a) Financial Statements of Businesses Acquired

The unaudited financial statements of the SinfoníaRx business, a business of Sinfonía HealthCare Corporation, as of June30, 2017 and for the six month periods ended June30, 2017 and 2016 filed herewith and attached hereto as Exhibit99.3 are incorporated herein by reference.

The audited financial statements of the SinfoníaRx business, a business of Sinfonía HealthCare Corporation as of December31, 2016 and 2015 and for each of the years ended December31, 2016 and 2015 filed herewith and attached hereto as Exhibit99.4 are incorporated herein by reference.

(b) Pro Forma Financial Information

The unaudited pro forma combined financial statements of TRHC, as of and for the six month period ended June30, 2017 and for the year ended December31, 2016 filed herewith and attached hereto as Exhibit99.5 are incorporated herein by reference.

(d) Exhibits.

ExhibitNumber

Description

2.1*

Agreement and Plan of Merger, dated September6, 2017, by and among Tabula Rasa HealthCare,Inc., TRCRD,Inc., TRSHC Holdings, LLC, Sinfonia HealthCare Corporation, Michael Deitch, Fletcher McCusker, and Michael Deitch, as Stockholders’ Representative (incorporated by reference to Exhibit2.1 to the registrant’s Current Report on Form8-K filed on September7, 2017).

10.1

Amended and Restated Loan and Security Agreement, dated September6, 2017, by and among CareKinesis,Inc., Tabula Rasa HealthCare,Inc., Careventions,Inc., Capstone Performance Systems, LLC, J.A. Robertson,Inc., Medliance LLC, CK Solutions, LLC, SinfoniaRx,Inc., Sinfonia HealthCare Corporation, TRCRD,Inc., TRSHC Holdings, LLC, the several banks and other financial institutions or entities from time to time party thereto, and Western Alliance Bank, as a Lender and as administrative agent and collateral agent for the Lenders (incorporated by reference to Exhibit10.1 to the registrant’s Current Report on Form8-K filed on September7, 2017).

23.1

Consent of BeachFleischman PC.

99.1

Press release of Tabula Rasa HealthCare,Inc. issued September6, 2017 (incorporated by reference to Exhibit99.1 to the registrant’s Current Report on Form8-K filed on September7, 2017).

99.2

Investor Presentation of Tabula Rasa HealthCare,Inc. dated September6, 2017 (incorporated by reference to Exhibit99.2 to the registrant’s Current Report on Form8-K filed on September7, 2017).


Tabula Rasa HealthCare, Inc. Exhibit
EX-23.1 2 a17-23997_1ex23d1.htm EX-23.1 Exhibit 23.1   Consent of Independent Public Accounting Firm   We consent to the incorporation by reference in the Registration Statements (Nos. 333-214025 and 333-216674) on Form S-8 of our report dated September 14,…
To view the full exhibit click here

About TABULA RASA HEALTHCARE,INC (NASDAQ:TRHC)

Tabula Rasa HealthCare, Inc. (Tabula Rasa), formerly CareKinesis, Inc., is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs. It also provides risk adjustment services, which help its clients to properly characterize a patient’s acuity, or severity of health condition, and optimize the associated payments for care. The Company serves approximately 100 healthcare organizations that focus on populations with complex healthcare needs and extensive medication requirements. Its products and services are built around the Medication Risk Mitigation Matrix, or MRM Matrix.